These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2695356)

  • 1. Interleukin 1 alpha and beta in psoriatic skin: enzymoimmunoassay, immunoblot studies and effect of systemic retinoids.
    Gruaz D; Didierjean L; Grassi J; Frobert Y; Dayer JM; Saurat JH
    Dermatologica; 1989; 179(4):202-6. PubMed ID: 2695356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between interleukin 6 and interleukin 1 levels in psoriatic lesional skin.
    Takematsu H; Tagami H
    Tohoku J Exp Med; 1994 Mar; 172(3):243-52. PubMed ID: 8073436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ localization of interleukin-1 in normal and psoriatic skin.
    Romero LI; Ikejima T; Pincus SH
    J Invest Dermatol; 1989 Oct; 93(4):518-22. PubMed ID: 2674299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A
    APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.
    Otkjaer K; Kragballe K; Funding AT; Clausen JT; Noerby PL; Steiniche T; Iversen L
    Br J Dermatol; 2005 Nov; 153(5):911-8. PubMed ID: 16225599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.
    Johansen C; Funding AT; Otkjaer K; Kragballe K; Jensen UB; Madsen M; Binderup L; Skak-Nielsen T; Fjording MS; Iversen L
    J Immunol; 2006 Feb; 176(3):1431-8. PubMed ID: 16424170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.
    Grossman RM; Krueger J; Yourish D; Granelli-Piperno A; Murphy DP; May LT; Kupper TS; Sehgal PB; Gottlieb AB
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6367-71. PubMed ID: 2474833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased levels of IL-1 alpha and beta in psoriatic lesional skin.
    Takematsu H; Ohmoto Y; Tagami H
    Tohoku J Exp Med; 1990 Jul; 161(3):159-69. PubMed ID: 2247888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1: a key inflammatory mediator in psoriasis?
    Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
    Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions.
    Ohta Y; Katayama I; Funato T; Yokozeki H; Nishiyama S; Hirano T; Kishimoto T; Nishioka K
    Arch Dermatol Res; 1991; 283(6):351-6. PubMed ID: 1796815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
    Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F
    J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis.
    Kristensen M; Deleuran B; Eedy DJ; Feldmann M; Breathnach SM; Brennan FM
    Br J Dermatol; 1992 Oct; 127(4):305-11. PubMed ID: 1419749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta.
    Cooper KD; Hammerberg C; Baadsgaard O; Elder JT; Chan LS; Sauder DN; Voorhees JJ; Fisher G
    J Immunol; 1990 Jun; 144(12):4593-603. PubMed ID: 2191038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of topical retinoic acid on the interleukin 1 alpha and beta immunoreactive pool in normal human epidermis.
    Gruaz DC; Didierjean L; Gumowski-Sunek D; Saurat JH
    Br J Dermatol; 1990 Sep; 123(3):283-9. PubMed ID: 2206968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
    J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8.
    Ameglio F; Bonifati C; Fazio M; Mussi A; Trento E; Cordial Fei P; Donati P; Pimpinelli F; D'Auria L; Carducci M
    Arch Dermatol Res; 1997 Jun; 289(7):399-403. PubMed ID: 9248618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
    Hammerberg C; Arend WP; Fisher GJ; Chan LS; Berger AE; Haskill JS; Voorhees JJ; Cooper KD
    J Clin Invest; 1992 Aug; 90(2):571-83. PubMed ID: 1386612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermis.
    Didierjean L; Salomon D; Mérot Y; Siegenthaler G; Shaw A; Dayer JM; Saurat JH
    J Invest Dermatol; 1989 Jun; 92(6):809-16. PubMed ID: 2656872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA, DNA, and cell surface characteristics of lesional and nonlesional psoriatic skin.
    Staiano-Coico L; Gottlieb AB; Barazani L; Carter DM
    J Invest Dermatol; 1987 May; 88(5):646-51. PubMed ID: 2437219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1-beta, interleukin-6, and interferon-gamma in suction blister fluids of involved and uninolved skin and in sera of psoriatic patients.
    Bonifati C; Ameglio F; Carducci M; Sacerdoti G; Pietravalle M; Fazio M
    Acta Derm Venereol Suppl (Stockh); 1994; 186():23-4. PubMed ID: 8073828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.